has been marketing the acrylamide reducing agent for a while now and revenues are such that they are proposing a 1:5 stock split on Dec 1st to make shares more available to retail investors. Further... THEY PAY A DIVIDEND.So... How are we doing ???
“l'm satisfied with the half-yearresults, and although we're seeing increasing general uncertainty concerning theglobal economic situation and increased volatility in our end markets, we’reable to maintain our sales and earnings growth guidance for the full year,”says Steen Riisgaard, President & CEO. He continues:“With the expectation of a stable cash flow improvement over the next couple ofyears, Novozymes has decided to initiate a stock buyback program and togradually increase the dividend payout ratio, both starting in 2012. Finally, tosupport liquidity and to make Novozymes’ stock more accessible to retailshareholders, it has been decided to make a 1:5 stock split, expected to beeffective as of December 1, 2011.”